Frontiers in Immunology (Feb 2021)

O-Linked N-Acetylglucosamine Modification of Mitochondrial Antiviral Signaling Protein Regulates Antiviral Signaling by Modulating Its Activity

  • Junghwa Seo,
  • Junghwa Seo,
  • Yun Soo Park,
  • Yun Soo Park,
  • Tae Hyun Kweon,
  • Tae Hyun Kweon,
  • Jingu Kang,
  • Jingu Kang,
  • Seongjin Son,
  • Seongjin Son,
  • Han Byeol Kim,
  • Yu Ri Seo,
  • Min Jueng Kang,
  • Eugene C. Yi,
  • Eugene C. Yi,
  • Yong-ho Lee,
  • Yong-ho Lee,
  • Jin-Hong Kim,
  • Jin-Hong Kim,
  • Boyoun Park,
  • Boyoun Park,
  • Won Ho Yang,
  • Won Ho Yang,
  • Jin Won Cho,
  • Jin Won Cho

DOI
https://doi.org/10.3389/fimmu.2020.589259
Journal volume & issue
Vol. 11

Abstract

Read online

Post-translational modifications, including O-GlcNAcylation, play fundamental roles in modulating cellular events, including transcription, signal transduction, and immune signaling. Several molecular targets of O-GlcNAcylation associated with pathogen-induced innate immune responses have been identified; however, the direct regulatory mechanisms linking O-GlcNAcylation with antiviral RIG-I-like receptor signaling are not fully understood. In this study, we found that cellular levels of O-GlcNAcylation decline in response to infection with Sendai virus. We identified a heavily O-GlcNAcylated serine-rich region between amino acids 249–257 of the mitochondrial antiviral signaling protein (MAVS); modification at this site disrupts MAVS aggregation and prevents MAVS-mediated activation and signaling. O-GlcNAcylation of the serine-rich region of MAVS also suppresses its interaction with TRAF3; this prevents IRF3 activation and production of interferon-β. Taken together, these results suggest that O-GlcNAcylation of MAVS may be a master regulatory event that promotes host defense against RNA viruses.

Keywords